University of Utah Health

COVID-19 Antibody Testing Needn’t be Perfect to Guide Public Health and Policy Decisions

19-May-2020 12:35 PM EDT, by University of Utah Health

While it’s too soon to use COVID-19 antibody testing to issue “immunity passports”, antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.

“We don’t need to wait for the perfect test to monitor populations. We can use what we have if we go in with our eyes open,” says University of Utah Health infectious disease physician-researcher Daniel Leung, M.D. He is corresponding author on the editorial together with specialists from seven different countries and leading public health institutions in the U.S., including Johns Hopkins Bloomberg School of Public Health, Harvard School of Public Health, University of California, San Francisco and Pennsylvania State University.

Today’s Tests are Ready for Populations, Not People

Some have suggested that detecting antibodies to SARS-CoV-2 — the coronavirus that causes COVID-19 — become the basis of “immunity passports” that enable people to return to work or school, or to travel. Yet, facts indicate that it is premature to take that step. For one, scientists have yet to determine whether the antibodies, or perhaps a threshold level of antibodies, protect a person from being re-infected. For another, there are multiple antibody tests, none with the levels of specificity needed to declare someone immune.

In short, we are far from being at a place where a positive antibody test guarantees that a person cannot get COVID-19 nor spread it to someone else, the authors say. And the stakes are too high to risk getting it wrong.

Regardless, these same tests are good enough to monitor the spread of COVID-19 in populations. “There is no need to throw out the baby with the bathwater,” says Leung. “We can use serological testing at the population level to get valuable information about transmission and the impact of interventions, and we don’t need a perfect serology test to do it.”

Understanding trends such as where outbreaks are occurring and which regions are quiet, and the characteristics of who is getting ill and who is protected, can provide information to guide policy. Is a specific county ready to ease restrictions? Are students safe to go back to school? Do certain populations need extra protection?

Fine-Tuning Existing Tests to Meet Different Needs

One reason many of today’s tests can work for public-level decisions is that they do not just give black and white answers. Instead, their parameters can be adjusted to fit different needs. One of these characteristics is specificity —  how well a test detects antibodies to SARS-CoV-2 and not to antibodies against other coronaviruses. The other is sensitivity — the minimum level of antibodies someone must have in their blood in order to test positive.

In general, there is a tradeoff between the two. Adjusting a test to prioritize sensitivity makes it not as specific, and making a test more specific makes it less sensitive. But it’s ok to sacrifice one for the other in order to answer certain questions, the editorial says.

Take the situation in a rural countryside where relatively few people have had COVID-19 per capita. In that setting, a test with high sensitivity and low specificity would not be optimal. These characteristics could easily result in the same number of people testing positive who never had COVID-19 as the number of people who really are positive. In this situation, the results would be practically meaningless.

However, the same test can be used if it is tuned for that situation. This can be done by designating a higher cutoff and saying that a test does not count as positive unless it has a stronger signal. Doing so lowers the false positive rate by increasing specificity. In this scenario, positive tests are more likely to be truly positive and that data can be safely used to monitor that population.

On the other hand, an urban setting where higher proportions of the population have been infected would do better with a test prioritized for higher sensitivity. That would give a better snapshot of the spread of COVID-19 by capturing a greater segment of the population.

“While we should certainly collect these data we need to make sure the right studies are put in place so we can meaningfully interpret these data for individuals and for populations,” says Andrew Azman, Ph.D., assistant scientist at the Johns Hopkins Bloomberg School of Public Health.

Additional studies will only make the results of antibody testing more informative. The editorial specifies that we still need to understand whether antibodies remain in the body for months or years, what levels of antibodies provide immunity, and how responses might differ in people who had various severity of infection, or who have other medical conditions.   

The authors say that equally as important as leveraging the technologies at hand is building an infrastructure that allows states and countries to share protocols, standardize methods, share results and coordinate activities. This would not only improve the response to the current pandemic but could build a foundation for monitoring other infectious diseases including influenza, cholera, malaria and future pandemics.

The editorial sums up the advantages that stand to be gained. “The current crisis presents an opportunity to rethink how health systems generate and use surveillance data and how to harness the power of serological tests and seroepidemiology.”

# # #

In addition to Leung, co-authors are Juliet Bryant, Andrew Azman, Matthew Ferrari, Benjamin Arnold, Maciej Boni, Yap Boum, Kyla Hayford, Francisco Luquero, Michael Mina, Isabel Rodriguez-Barraquer, Joseph Wu, Djibril Wade and Guy Vernet. In addition to the institutions mentioned, collaborators come from Fondation Mérieux, Médecins Sans Frontières, Epicentre in Yaounde and Paris, University of Hong Kong, IRESSEF, Dakar and Institut Pasteur de Bangui.

The editorial published as “Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward”.

About University of Utah Health

University of Utah Health provides leading-edge and compassionate medicine for a referral area that encompasses 10% of the U.S., including Idaho, Wyoming, Montana and much of Nevada. A hub for health sciences research and education in the region, U of U Health has a $373 million research enterprise and trains the majority of Utah’s physicians, including more than 1,250 health care providers each year at its Schools of Medicine and Dentistry and Colleges of Nursing, Pharmacy and Health. With more than 20,000 employees, the system includes 12 community clinics and four hospitals. For ten straight years, U of U Health has ranked among the top 10 U.S. academic medical centers in the Vizient Quality and Accountability Study. 

 

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 2887
Released: 12-Aug-2020 3:50 PM EDT
MTSU, Texas State professors posit pandemic offers 'largest criminological experiment in history'
Middle Tennessee State University

In a research paper published in the American Journal of Criminal Justice, Ben Stickle, an associate professor of criminal justice administration, posits that the novel coronavirus tragedy presents a unique opportunity for a “randomized control trial.” The paper is co-authored by Stickle and Marcus Felson of Texas State University in San Marcos, Texas.

Newswise:Video Embedded clearing-confusion-on-asymptomatic-spread
VIDEO
Released: 12-Aug-2020 3:30 PM EDT
Clearing confusion on asymptomatic spread
UW Medicine

Confusion abounds about the difference between asymptomatic and pre-symptomatic infections when it comes to the pandemic coronavirus. Dr. John Lynch, medical director of infection prevention and control at Harborview, explains what it means.

Released: 12-Aug-2020 2:35 PM EDT
Survey Results Detail Signs of Improving Conditions for CRNAs
American Association of Nurse Anesthetists (AANA)

The American Association of Nurse Anesthetists (AANA) discovered in a new survey that employment opportunities for Certified Registered Nurse Anesthetists (CRNAs) during the COVID-19 public health crisis is improving.

Released: 12-Aug-2020 2:05 PM EDT
Combating child weight gain during COVID-19
University of Texas Health Science Center at Houston

The infamous “Quarantine 15,” a reference to packing on the pounds during the pandemic, is affecting even the youngest of Americans, according to UT Physicians pediatricians, who are seeing the evidence in front of them via telemedicine appointments.

Newswise:Video Embedded jhu-robotic-system-remotely-controls-ventilators-in-covid-19-patient-rooms
VIDEO
Released: 12-Aug-2020 1:10 PM EDT
JHU Robotic System Remotely Controls Ventilators In COVID-19 Patient Rooms
Johns Hopkins University

A new robotic system allows medical staff to remotely operate ventilators and other bedside machines from outside intensive care rooms of patients suffering from infectious diseases.

Newswise: Sandia Science & Tech Park spurs economic growth
Released: 12-Aug-2020 1:05 PM EDT
Sandia Science & Tech Park spurs economic growth
Sandia National Laboratories

A new, independent report has concluded that the Sandia Science & Technology Park contributed significantly to the local economy in 2018-19 by adding 310 jobs and generating increases in economic activity and tax revenue to the city and New Mexico.

Newswise: Sciatica – A Common “Pain in the Nerve” for All Ages
Released: 12-Aug-2020 12:55 PM EDT
Sciatica – A Common “Pain in the Nerve” for All Ages
Hackensack Meridian Health

COVID-19 stay-at-home guidelines have created many lifestyle changes, including new home workout routines and do-it-yourself home improvement projects. Doctors warn, however, that increased activity for those not used to certain exertion levels can lead to strains and pains, including one of the most common nerve conditions, sciatica (sy-at’-ick-uh).

Released: 12-Aug-2020 12:10 PM EDT
Grant boosts psychosocial care resources during COVID-19 pandemic
University of California, Los Angeles (UCLA), Health Sciences

The Simms/Mann-UCLA Center for Integrative Oncology has received a $50,000 grant from Los Angeles-based PHASE ONE Foundation to support psychosocial care for people with cancer, their families and frontline healthcare workers during the COVID-19 pandemic.

Newswise: When can kids return to sports after COVID-19? Doctors weigh in
Released: 12-Aug-2020 12:05 PM EDT
When can kids return to sports after COVID-19? Doctors weigh in
University of Virginia Health System

Pediatric cardiologists are offering important advice on if and when it is safe for children and teens to return to playing sports after recovering from COVID-19.

Released: 12-Aug-2020 9:15 AM EDT
Mount Sinai’s Arnhold Institute for Global Health Partners with NYC Health + Hospitals on COVID-19 Unit for Research at Elmhurst (CURE-19)
Mount Sinai Health System

Collaboration Brings Together Clinicians and Researchers on the Front Lines of COVID-19 to Support Innovative Solutions for Health Disparities


Showing results

110 of 2887

close
2.87726